Furthermore, we propose that changes in IL-6 correlate with changes in nephrin, podocin, KIM-1 and albumin-to-creatinine ratio, highlighting calcitriol’s potential therapeutic role in the early management of DKD. This evidence concerns the gene HAVCR1 and diabetic kidney disease.